XML 31 R20.htm IDEA: XBRL DOCUMENT v3.24.2.u1
NATURE OF OPERATIONS (Narrative) (Details) - USD ($)
$ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jan. 30, 2023
Mar. 31, 2024
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Accumulated deficit     $ (224,671)   $ (224,671)   $ (220,303)
Sales amount     $ 5,433 $ 594 $ 5,899 $ 894  
PellePharm, Inc. [Member] | Asset Purchase Agreement [Member] | Development And Nda Acceptance Milestones [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Sales milestone payments $ 6,000            
PellePharm, Inc. [Member] | Asset Purchase Agreement [Member] | Commercial Milestones [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Sales milestone payments $ 64,000            
Description of upfront payment $4 million to PellePharm. The Company is required to pay an additional amount of $0.7 million, subject to the terms as defined in the APA, 15 months from the closing date.            
Increase in sales milestone amount due to sales exceed dollar 500 million $ 89,000            
Sales amount $ 500,000            
Clinical expenses   $ 500